- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Launch of Cannabis Science and Technology Magazine
Our new sister publication, Cannabis Science and Technology (CST), launched in March 2018. In alliance with the Cannabis Science Conference, this new professional journal and website will focus on educating the legal cannabis industry about the science and technology of analytical testing and quality control, including topics such as
· Sample preparation techniques for analytical testing
· Development of analytical methods for potency testing
· Identifying contaminants such as pesticides, residual solvents, heavy metals, and mycotoxins
· Quality control for cannabis, extraction, and processing
· Laboratory best practices and certification
· Testing standardization
· Regulations related to quality control
The first issue features content ranging from quality assurance, laboratory accreditation, analytical tools to analyze edibles, metals analysis, extraction processes, and more. To read the full issue, please visit www.cannabissciencetech.com/journal/cannabis-science-and-technology-vol-1-no-1 or download the digital edition.
If you would like to submit an article to Cannabis Science and Technology, contact Meg L’Heureux, Editor-in-Chief at Meg.Lheureux@ubm.com.
For subscription information, please visit http://www.cannabissciencetech.com/subscribe
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
